SKIN The Beauty Health Company
Consumer Defensive$0.86+24.81%ClosedMarket Cap: $111.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.59
P/S
0.30
EV/EBITDA
5.88
DCF Value
$-13.60
FCF Yield
31.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
64.9%
Operating Margin
-3.6%
Net Margin
-2.0%
ROE
-9.4%
ROA
-1.3%
ROIC
-2.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $64.9M | 68.4% | $-1.8M | $-6.6M | $— | — |
| Q4 null | $82.4M | 64.4% | $162.0K | $-8.1M | $— | — |
| FY null | $300.8M | 65.3% | $-20.8M | $-9.5M | $— | — |
| Q3 null | $70.7M | 64.6% | $-6.2M | $-11.0M | $— | — |
| Q2 null | $78.2M | 62.8% | $-2.7M | $19.7M | $— | — |
| Q1 null | $69.6M | 69.8% | $-12.0M | $-10.1M | $— | — |
| Q4 null | $83.5M | 62.7% | $-7.2M | $-10.3M | $— | — |
| FY null | $334.3M | 54.5% | $-67.8M | $-29.1M | $— | — |
| Q3 null | $78.8M | 51.6% | $-21.5M | $-18.3M | $— | — |
| Q2 null | $90.6M | 45.2% | $-22.1M | $202.0K | $— | — |
| Q1 null | $81.4M | 59.4% | $-17.0M | $-679.0K | $— | — |
| Q4 2023 | $96.8M | 47.2% | $-18.4M | $-9.4M | $-0.07 | — |